Tech Expert Announces New #1 ASX Pick

By: Adam Surplice

Doctor Anirban Mahanti – The Motley Fool Australia's resident tech stock expert – has discovered one fast growing tech stock that he likes so much that he's officially recommending it as a "double down" opportunity.

I've worked for The Motley Fool for a number of years and can count on one hand the number of times one of our Investment Advisors has put a buy recommendation ON THE EXACT SAME STOCK for the second month in a row.

In other words, this is about as close to a STRONG BUY recommendation as you can get.

Although this is the first time Doc has recommended the same stock for two months in a row, he has issued "double down" opportunities in the past.

One medical technology stock is up 79% in less than a year… coming on top of the 150% gain from the time he first recommended the company as a buy.

Another cloud-based software stock is up 92% in a little over a year… coming on top of the 138% gain from the time he first recommended the medical technology company as a buy!

And this brand new "double down" pick looks poised for big gains, too.

For starters, this company is emerging as the "top dog" in an important digital industry, with a growing base of customers in Australia and around the world…

Which is why the company's most recent half year report saw revenue increase 60%, while profits grew an eye-watering 17X.

That's the kind of growth you only ever see in the crucial EARLY STAGES of next-big-thing tech companies. And the biggest gains still look to be ahead.

As Doc Mahanti himself put it, "With operating profit growing faster than revenue, we are starting to see operating leverage in the business model shine. At scale, we would expect this business to be gushing cash flow."

As you may know, Doc Mahanti is the Investment Advisor of Motley Fool Extreme Opportunities, one of our newest stock picking services.

Here's why I'm convinced you should join us in Extreme Opportunities today.

As a brand new Motley Fool Extreme Opportunities member, you'll not only get access Doc's brand new STRONG BUY recommendation…

Including the name, code and a full investment analysis…

You'll also get a brand new "Extreme" stock pick every single month as long as you're a member…

Instant access to ALL the current live buy recommendations on the Extreme Opportunities list…

Our monthly "best buys now" report, where Doc reviews the full list of current buy recommendations and narrows it down to just the three Extreme Opportunities stocks to buy right now.

PLUS: You'll also have the chance to instantly download Doc's recent research report, "One Small ASX Biotech Could Utterly Transform Cancer Treatment," where Doc names the one tiny ASX biotech company t he thinks has substantial upside potential!

It all boils down to this:

Inside Motley Fool Extreme Opportunities are stocks that, if everything goes right, could make you as much as four or five times your money.

And because I'm keen to get this stock research into as many hands as possible…

I'm going to offer you a $300 discount if you act right now and sign up to a one year subscription to Motley Fool Extreme Opportunities.

So instead of paying $399 today…

You can pay just $99 for a full one-year subscription to Doc's Motley Fool Extreme Opportunities.


You stand to save $300 off your first year if you act NOW. Simply enter your email address below, and you'll be taken to our secure order form. Joining takes two minutes or less.

And as I'm sure you'll appreciate, time is of the essence. Doc has just released his brand new STRONG BUY recommendation… but the stock is already on the move.

So if you want to get in as close to the "ground floor" as possible, you'll have to act right now.

Please understand that, given the heavy discount on offer, we do reserve the right to remove this offer without notice.

So I urge you sign up to Motley Fool Extreme Opportunities, before it's too late. Claim your $300 off discount, while it lasts.

This is your chance to get in early on what could prove to be a very special "double down" investment recommendation.

Doc's past "double down" recommendations have shot up as much as 92% in a single year.

And while there's no sure thing when it comes to investing, we believe this new "double down" could be Doc's biggest yet.

Now think about how many investing trends you've missed out on even though you knew they were going to be big…

Don't let that happen again. This is your chance to get in early.

I urge you to take action today and decide for yourself if you want to take advantage of this potentially once-in-a-generation buying opportunity.

Simply enter your email address below to access our secure sign-up page!

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe at anytime. Please refer to our Financial Services Guide (FSG) for more information.

Returns as of 9/4/19. Adam Surplice does not own any of the shares mentioned. The Motley Fool Australia owns shares of Corporate Travel Management Limited andPremier Investments Limited. For more information about The Motley Fool see our Financial Services Guide. All returns cited are hypothetical and based on the percentage change between the stock price at the time of recommendation and the current or sell price (if the position has been closed) at the time of publication. Brokerage, taxes and any other associated costs are not taken into account. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.